To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Nurse Navigation Program on Lung Cancer Patients
NCT ID:
NCT05937425
Condition:
Non Small Cell Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
Cancer
Nurse Navigator
Nurse Navigation Program
Individualized Care
Anxiety-Depression
Adaptation to the Disease
Quality of Life
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
This is a randomized controlled trial consisting of two groups: experimental and control.
Primary purpose:
Supportive Care
Masking:
Single (Outcomes Assessor)
Masking description:
Single Blind (Outcomes Assessor)
Intervention:
Intervention type:
Other
Intervention name:
LungCaNN
Description:
The needs of the patients included in the study will be determined with the supportive
care needs scale. A training booklet will be given to the patients in the intervention
group and they will be informed about the existing or newly formed unsupported care
needs, the evaluation of their frequency and severity, and the ability of the patients to
call the navigator nurse 24/7 or send an SMS. For interventions that can be applied in
line with evidence-based guidelines for unsupported care needs with patients included in
the intervention group every week for 12 weeks, a face-to-face navigation will be made by
the navigator nurse over the phone and once a month.
Arm group label:
Intervention group
Summary:
The study aims to determine the effect of the nurse navigation program (LungCaNN), which
is performed in line with the supportive care needs of newly diagnosed non-small cell
lung cancer patients, on the level of anxiety-depression, adherence to the disease, and
quality of life.
The study was designed as a randomized study with a control group. This study will be
carried out with a total of 84 NSCLC patients, 42 of whom were in the intervention group
and 42 in the control group, whose treatment was started in Akdeniz University Medical
Oncology Outpatient Clinic and met the inclusion criteria of the sampling. Nurse
navigation program will be applied for 12 weeks from the diagnosis of NSCLC patients in
the intervention group. The intervention protocol of the study is abbreviated as "Lung
Cancer Nurse Navigator" [LungCaNN].
Within the scope of the LungCaNN program, face-to-face patient education, patient
education booklet, face-to-face, and telephone navigation initiatives were planned.
Patient Identification Form, Depression Anxiety Stress Scale (DASS 21), Chronic Disease
Adjustment Scale, EORTC QLQ 30 Quality of Life Scale-/ LC-13, and Navigation and
Interview Steps Form will be used to collect data.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Know how to read and write No hearing or speech problems Be able to use the phone
The primary medical diagnosis is non-small cell lung cancer Karnofsky Performance
Scale score of 70% or higher Patients with a stress thermometer of 4 and above At
most six weeks past the date of diagnosis
Exclusion Criteria:
- Patients with cognitive problems Expected life expectancy is less than three months
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
February 5, 2024
Completion date:
August 30, 2024
Lead sponsor:
Agency:
Akdeniz University
Agency class:
Other
Source:
Akdeniz University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05937425
